XTL BIOPHARMACEUTICALS LTD. Share Premium
XTL BIOPHARMACEUTICALS LTD. (XTLB) had Share Premium of $147.71 million as of 2019-12-31, per its 20-F filed 2020-03-12.
Discontinued › Notes
ifrs-full:SharePremium · last filed 2020-03-12
- 2019-12-31: Share Premium $147.71M.
- 2018-12-31: Share Premium $147.71M.
- 2017-12-31: Share Premium $146.01M.
- 2016-12-31: Share Premium $150.78M.
| Period end | Share Premium |
|---|---|
| 2019-12-31 | $147.71M 20-F · filed 2020-03-12 |
| 2018-12-31 | $147.71M 20-F · filed 2020-03-12 |
| 2017-12-31 | $146.01M 20-F · filed 2019-03-11 |
| 2016-12-31 | $150.78M 20-F · filed 2018-03-15 |